創業板註冊制試點方案重磅出爐!中資券商股全線上漲,中金(3908.HK)漲超7%
格隆匯4月28日丨港股市場中資券商股全線上漲,其中,中金公司漲超7%領漲,中國銀河漲超5%,中信證券漲超4%,廣發證券、中信建投和華泰證券均漲超3%,東方證券、海通證券、招商證券均漲超2%。
創業板註冊制試點方案昨晚重磅出爐,機構普遍認為利好券商和創投板塊。中金報告指出,創業板註冊制啟動將帶來短期交易活躍度提升、中長期業務擴容以及模式升級,當前估值處於歷史偏低水平的中資券商股有望迎來估值修復。報告指出,深化資本市場改革有望帶來投行業務的擴容,同時,交易機制的放寬以及更多新經濟企業的上市有望提振交投活躍度,增厚經紀相關業務收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.